EUVIMEDOpdag EUVIMED
EditorialOpen access

Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply

Nicolas Richard, Mathurin Fumery

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 546-547

DOI: 10.1111/apt.70817 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-06-20. Written by Nicolas Richard and 1 co-authors. Institution: Department of Gastroenterology, Univ Rouen Normandie, INSERM, ADEN UMR1073, "Nutrition, Inflammation and Microbiota-Gut-Brain Axis", CHU Rouen, Rouen…. Cited 1 times so far (Crossref); 7 references. The full text is freely available in PubMed Central.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Authors and institutions

  • Department of Gastroenterology, Univ Rouen Normandie, INSERM, ADEN UMR1073, "Nutrition, Inflammation and Microbiota-Gut-Brain Axis", CHU Rouen, Rouen, France.
  • Department of Gastroenterology, Amiens University Hospital and PeriTox, Université de Picardie, Amiens, France.

Cite

APA

Richard, N., & Fumery, M. (2026). Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(4), 546-547. https://doi.org/10.1111/apt.70817

Vancouver

Richard N, Fumery M. Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(4):546-547. doi:10.1111/apt.70817

BibTeX
@article{Richard2026,
  author = {Richard, Nicolas and Fumery, Mathurin},
  title = {Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {4},
  pages = {546--547},
  doi = {10.1111/apt.70817}
}
Start for free →